Amidon GL - Search Results

1

Overview of membrane transport.

Oh DM, Amidon GL. Oh DM, et al. Among authors: amidon gl. Pharm Biotechnol. 1999;12:1-27. doi: 10.1007/0-306-46812-3_1. Pharm Biotechnol. 1999. PMID: 10742970 Review.

2

Intranasal absorption of flurazepam, midazolam, and triazolam in dogs.

Lui CY, Amidon GL, Goldberg A. Lui CY, et al. Among authors: amidon gl. J Pharm Sci. 1991 Dec;80(12):1125-9. doi: 10.1002/jps.2600801207. J Pharm Sci. 1991. PMID: 1815070

3

Membrane permeability parameters for some amino acids and beta-lactam antibiotics: application of the boundary layer approach.

Hu M, Sinko PJ, deMeere AL, Johnson DA, Amidon GL. Hu M, et al. Among authors: amidon gl. J Theor Biol. 1988 Mar 7;131(1):107-14. doi: 10.1016/s0022-5193(88)80124-3. J Theor Biol. 1988. PMID: 3419188

4

Modulated drug release using iontophoresis through heterogeneous cation-exchange membranes. 2. Influence of cation-exchanger content on membrane resistance and characteristic times.

Schwendeman SP, Amidon GL, Labhasetwar V, Levy RJ. Schwendeman SP, et al. Among authors: amidon gl. J Pharm Sci. 1994 Oct;83(10):1482-94. doi: 10.1002/jps.2600831023. J Pharm Sci. 1994. PMID: 7884674

5

Role of integrin expression in adenovirus-mediated gene delivery to the intestinal epithelium.

Croyle MA, Walter E, Janich S, Roessler BJ, Amidon GL. Croyle MA, et al. Among authors: amidon gl. Hum Gene Ther. 1998 Mar 1;9(4):561-73. doi: 10.1089/hum.1998.9.4-561. Hum Gene Ther. 1998. PMID: 9525317

6

Determination of the population pharmacokinetic parameters of sustained-release and enteric-coated oral formulations, and the suppository formulation of diclofenac sodium by simultaneous data fitting using NONMEM.

Idkaidek NM, Amidon GL, Smith DE, Najib NM, Hassan MM. Idkaidek NM, et al. Among authors: amidon gl. Biopharm Drug Dispos. 1998 Apr;19(3):169-74. doi: 10.1002/(sici)1099-081x(199804)19:3<169::aid-bdd83>3.0.co;2-c. Biopharm Drug Dispos. 1998. PMID: 9570000

7

Saturable small intestinal drug absorption in humans: modeling and interpretation of cefatrizine data.

Yu LX, Amidon GL. Yu LX, et al. Among authors: amidon gl. Eur J Pharm Biopharm. 1998 Mar;45(2):199-203. doi: 10.1016/s0939-6411(97)00088-x. Eur J Pharm Biopharm. 1998. PMID: 9704917

8

Development of a highly efficient purification process for recombinant adenoviral vectors for oral gene delivery.

Croyle MA, Anderson DJ, Roessler BJ, Amidon GL. Croyle MA, et al. Among authors: amidon gl. Pharm Dev Technol. 1998 Aug;3(3):365-72. doi: 10.3109/10837459809009864. Pharm Dev Technol. 1998. PMID: 9742557

9

Factors that influence stability of recombinant adenoviral preparations for human gene therapy.

Croyle MA, Roessler BJ, Davidson BL, Hilfinger JM, Amidon GL. Croyle MA, et al. Among authors: amidon gl. Pharm Dev Technol. 1998 Aug;3(3):373-83. doi: 10.3109/10837459809009865. Pharm Dev Technol. 1998. PMID: 9742558

10

CHO/hPEPT1 cells overexpressing the human peptide transporter (hPEPT1) as an alternative in vitro model for peptidomimetic drugs.

Han HK, Rhie JK, Oh DM, Saito G, Hsu CP, Stewart BH, Amidon GL. Han HK, et al. Among authors: amidon gl. J Pharm Sci. 1999 Mar;88(3):347-50. doi: 10.1021/js980132e. J Pharm Sci. 1999. PMID: 10052994

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results